FDA Inspection 1234333 — Boston Medical Center and Boston University Medical Campus IRB
The FDA completed an inspection of Boston Medical Center and Boston University Medical Campus IRB on March 22, 2024 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 22, 2024
- Fiscal Year
- 2024
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Boston, MA (United States)
Additional Details
IRB